Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern.

Effenberger KE, Borgen E, Eulenburg CZ, Bartkowiak K, Grosser A, Synnestvedt M, Kaaresen R, Brandt B, Nesland JM, Pantel K, Naume B.

Breast Cancer Res Treat. 2011 Feb;125(3):729-38. doi: 10.1007/s10549-010-0911-2. Epub 2010 May 7.

PMID:
20449649
2.

Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells.

Borgen E, Naume B, Nesland JM, Kvalheim G, Beiske K, Fodstad O, Diel I, Solomayer EF, Theocharous P, Coombes RC, Smith BM, Wunder E, Marolleau JP, Garcia J, Pantel K.

Cytotherapy. 1999;1(5):377-88. doi: 10.1080/0032472031000141283.

PMID:
20426539
3.

Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer.

Rahbari NN, Aigner M, Thorlund K, Mollberg N, Motschall E, Jensen K, Diener MK, Büchler MW, Koch M, Weitz J.

Gastroenterology. 2010 May;138(5):1714-26. doi: 10.1053/j.gastro.2010.01.008. Epub 2010 Jan 25.

PMID:
20100481
4.

Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches.

McGowan PM, Kirstein JM, Chambers AF.

Future Oncol. 2009 Sep;5(7):1083-98. doi: 10.2217/fon.09.73. Review.

PMID:
19792975
5.

The emerging role of EpCAM in cancer and stem cell signaling.

Munz M, Baeuerle PA, Gires O.

Cancer Res. 2009 Jul 15;69(14):5627-9. doi: 10.1158/0008-5472.CAN-09-0654. Epub 2009 Jul 7. Review.

6.

Cancer micrometastases.

Pantel K, Alix-Panabières C, Riethdorf S.

Nat Rev Clin Oncol. 2009 Jun;6(6):339-51. doi: 10.1038/nrclinonc.2009.44. Review.

PMID:
19399023
7.

Nuclear signalling by tumour-associated antigen EpCAM.

Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M, Kieu C, Papior P, Baeuerle PA, Munz M, Gires O.

Nat Cell Biol. 2009 Feb;11(2):162-71. doi: 10.1038/ncb1824. Epub 2009 Jan 11.

PMID:
19136966
8.

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.

Fehm T, Braun S, Muller V, Janni W, Gebauer G, Marth C, Schindlbeck C, Wallwiener D, Borgen E, Naume B, Pantel K, Solomayer E.

Cancer. 2006 Sep 1;107(5):885-92.

9.
10.

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.

O'Connell JB, Maggard MA, Ko CY.

J Natl Cancer Inst. 2004 Oct 6;96(19):1420-5.

PMID:
15467030
11.

Clinical practice. Surveillance strategies after curative treatment of colorectal cancer.

Pfister DG, Benson AB 3rd, Somerfield MR.

N Engl J Med. 2004 Jun 3;350(23):2375-82. Review. No abstract available.

PMID:
15175439
12.

Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients.

Gangnus R, Langer S, Breit E, Pantel K, Speicher MR.

Clin Cancer Res. 2004 May 15;10(10):3457-64.

13.

Dissemination and growth of cancer cells in metastatic sites.

Chambers AF, Groom AC, MacDonald IC.

Nat Rev Cancer. 2002 Aug;2(8):563-72. Review.

PMID:
12154349
14.

Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients.

Flatmark K, Bjørnland K, Johannessen HO, Hegstad E, Rosales R, Hårklau L, Solhaug JH, Faye RS, Søreide O, Fodstad Ø; Study Group for Micrometastases in BM in Colorectal Cancer.

Clin Cancer Res. 2002 Feb;8(2):444-9.

Supplemental Content

Support Center